Professor Holtzman said the result implied that apoE and clusterin worked together to suppress plaque formation by clearing amyloidprotein from the brain tissue and surrounding fluid.
Harvard University researchers conducted experiments on mice using oligomers, a soluble form of amyloid-beta protein, which is the key compound in brain plaque and a hallmark of Alzheimer's.